Sigma Planning Corp’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,124
Closed -$19.1K 1333
2025
Q4
$19.1K Sell
11,124
-7,600
-41% -$20.8K ﹤0.01% 1289
2025
Q3
$57.3K Buy
18,724
+500
+3% +$1.43K ﹤0.01% 1274
2025
Q2
$50.8K Buy
+18,224
New +$59.9K ﹤0.01% 1227
2024
Q4
Sell
-10,324
Closed -$29.1K 1182
2024
Q3
$29.1K Buy
+10,324
New +$23.6K ﹤0.01% 1195
2023
Q4
Sell
-10,274
Closed -$11.1K 902
2023
Q3
$11.1K Sell
10,274
-500
-5% -$595 ﹤0.01% 1186
2023
Q2
$9.66K Hold
10,774
﹤0.01% 1192
2023
Q1
$9.11K Buy
10,774
+74
+0.7% +$81 ﹤0.01% 1289
2022
Q4
$9.95K Hold
10,700
﹤0.01% 1247
2022
Q3
$18K Hold
10,700
﹤0.01% 1245
2022
Q2
$23K Sell
10,700
-250
-2% -$664 ﹤0.01% 1269
2022
Q1
$39K Sell
10,950
-1,000
-8% -$2.9K ﹤0.01% 1340
2021
Q4
$44K Buy
+11,950
New +$73.3K ﹤0.01% 1359
2021
Q2
Sell
-49,886
Closed -$377K 1430
2021
Q1
$377K Buy
+49,886
New +$563K 0.01% 888

Other funds holding CLOV

Sigma Planning Corp's CLOV Position: Q1 2026 in Review

Sigma Planning Corp sold out of Clover Health Investments (CLOV) in Q1 2026, closing a stake of 11,124 shares — an estimated $19.1K sold.

Sigma Planning Corp first reported a position in CLOV in Q1 2021 and held it in 13 quarters. The position peaked at $377K in Q1 2021. 209 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Sigma Planning Corp reported no remaining Clover Health Investments position as of Q1 2026 after selling out during the quarter.
  • Sigma Planning Corp sold 11,124 Clover Health Investments shares in Q1 2026, an estimated $19.1K.
  • Sigma Planning Corp first reported a position in Clover Health Investments in Q1 2021 and held it in 13 quarters.
  • Sigma Planning Corp's Clover Health Investments position peaked at $377K in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.